BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26709864)

  • 1. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
    Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
    Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
    Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
    J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk.
    Penn MS; Yenikomshian MA; Cummings AK; Klemes A; Damron JM; Purvis S; Beidelschies M; Birnbaum HG
    J Med Econ; 2015; 18(7):483-91. PubMed ID: 25763924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
    Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
    Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes.
    Saratzis A; Harrison S; Barratt J; Sayers RD; Sarafidis PA; Bown MJ
    Am J Nephrol; 2015; 42(4):285-94. PubMed ID: 26495853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
    Özcan C; Deleskog A; Schjerning Olsen AM; Nordahl Christensen H; Lock Hansen M; Hilmar Gislason G
    Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):25-35. PubMed ID: 28444162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.
    Jernberg T; Hasvold P; Henriksson M; Hjelm H; Thuresson M; Janzon M
    Eur Heart J; 2015 May; 36(19):1163-70. PubMed ID: 25586123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
    Fox KM; Wang L; Gandra SR; Quek RGW; Li L; Baser O
    BMC Cardiovasc Disord; 2016 Jan; 16():13. PubMed ID: 26769473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cardiovascular risk factors, events, and costs across four BMI categories.
    Brixner DI; Bron M; Bellows BK; Ye X; Yu J; Raparla S; Oderda GM
    Obesity (Silver Spring); 2013 Jun; 21(6):1284-92. PubMed ID: 23913737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term all-cause and cardiovascular mortality following incident myocardial infarction in men and women with and without diabetes: Temporal trends from 1998 to 2009.
    Nedkoff L; Knuiman M; Hung J; Briffa TG
    Eur J Prev Cardiol; 2016 Aug; 23(12):1273-81. PubMed ID: 26907793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry.
    Pocock SJ; Brieger D; Gregson J; Chen JY; Cohen MG; Goodman SG; Granger CB; Grieve R; Nicolau JC; Simon T; Westermann D; Yasuda S; Hedman K; Rennie KL; Sundell KA;
    Clin Cardiol; 2020 Jan; 43(1):24-32. PubMed ID: 31713893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
    Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
    J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.
    Trivedi H; Xiang Q; Klein JP
    Nephrol Dial Transplant; 2009 Jan; 24(1):258-66. PubMed ID: 18682489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.